Skip to main content
. 2017 Oct 7;8(61):103108–103116. doi: 10.18632/oncotarget.21600

Figure 2. Kaplan-Meier survival curves of patients according to prior chemotherapy.

Figure 2

(A) no impact of prior chemotherapy on overall survival. (B) Overall survival considering the number of lines of chemotherapy. Although patients with the history of both docetaxel and cabazitaxel show longer median overall survival, this difference was not significant.